Group-Based Exercise Intervention to Prevent Cognitive and Motor Decline

March 19, 2026 updated by: Francesca Morganti, University of Bergamo

Effects of the Ideomotor Group Program Exercise on Cognitive Functioning, Motor Functioning and Overall Well-being in Community-Dwelling Older Adults

The goal of this clinical trial is to evaluate the efficacy of the Ideomotor Program in healthy older adults living in the community. The main research questions are:

1) Is the Ideomotor Program effective in improving cognitive function? 2) Is the Ideomotor Program effective in improving motor function? 3) Is the Ideomotor Program effective in improving overall well-being?

Researchers will compare the Ideomotor Program to a community group cognitive training program to determine whether the effects are superior. Participants will: undergo assessments at baseline, at the mid-intervention point, and upon program completion; participate in a 16-week group exercise program in a community gym two times per week; keep a diary to monitor the number of falls and any adverse events.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

158

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • BG
      • Bergamo, BG, Italy, 24124
        • Not yet recruiting
        • University of Bergamo - S. Agostino
        • Contact:
    • Bergamo
      • Bergamo, Bergamo, Italy, 24129
        • Recruiting
        • Centre for Healthy Longevity
        • Contact:
        • Principal Investigator:
          • Inaihá L Benincá, PhD Student

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • At least 50 years old;
  • Able to move independently;
  • Live in the community;
  • Demonstrated ability to comprehend complex verbal instructions.

Exclusion Criteria:

  • Presence of severe neurological and psychological conditions;
  • Less than 9,36 score in the FAB15;
  • Lack of medical clearance to participate in an exercise program;
  • Less than 75% of attendance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ideomotor Group Exercise Program
The intervention group will follow the Ideomotor Program, attending group sessions with a maximum of 12 participants over a period of 16 weeks. The protocol is structured into two weekly sessions, each lasting 60 minutes. The workout combines physical and cognitive exercises using a mind-motor training approach, incorporating aerobic and functional activities, except for one quarter of the weekly training, which consists of high-velocity muscle power exercises performed without a cognitive component.

The Ideomotor Program sessions will include the following:

  1. Warm-up Light-intensity physical-cognitive exercises.
  2. Work-out 1 Mind-Motor:

    Stimulates physical and cognitive abilities through functional exercises.

  3. Work-out 2 3.1) Mind-Motor: stimulate physical and cognitive abilities through aerobic exercises (once a week) 3.2) Work-out 2 Motor only: high-velocity muscle power exercises (once a week).
  4. Cool-down: light-intensity walking or dynamic stretching combined with breathing
  5. Socialization: dedicated moment to encourage socialization. Participants' feedback will be received once a month.
Other Names:
  • Ideomotor Group Exercise Program
Active Comparator: Cognitive training program
The control group will participate in a group-based cognitive training program without a motor component. This training matches the experimental group in terms of cognitive training dose, session duration, and number of participants. The program is based on cognitive exercises considered the gold standard for cognitive training.

The Group-based cognitive training will include the following:

  1. Warm-up: cognitive exercises designed for training basic cognitive abilities in adults and older adults;
  2. Work-out: cognitive exercises designed for training complex cognitive abilities in adults and older adults;
  3. Cool-down: moment for discussion of the exercises and their possible solutions;
  4. Socialization: dedicated moment to encourage socialization. Participants' feedback will be received once a month.
Other Names:
  • Group-based cognitive training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Executive functions
Time Frame: At baseline and at the end of the intervention period (week 17)
The Frontal Assessment Battery-15 will be used to access changes from baseline in executive functions (score range: 0-15, higher scores mean a better outcome)
At baseline and at the end of the intervention period (week 17)
Cognitive flexibility
Time Frame: At baseline and at the end of the intervention period (week 17)
Wisconsin Card Sorting Test will be used to assess changes from baseline in cognitive flexibility (score range perseverative errors: 0-64, higher scores mean a worse outcome)
At baseline and at the end of the intervention period (week 17)
Short-term and working memory
Time Frame: At baseline and at the end of the intervention period (week 17)
The Digit span test (forward and backward) will be used to assess from baseline changes in short-term and working memory (foward score range: 3-9, backward score range: 3-8; higher scores mean a better outcome)
At baseline and at the end of the intervention period (week 17)
Visuo-spatial short term working memory
Time Frame: At baseline and at the end of the intervention period (week 17)
The Corsi Block-Tapping Test will be used to assess changes from baseline in visuo-spatial short term working memory (score range: 2-9, higher scores mean a better outcome)
At baseline and at the end of the intervention period (week 17)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Movement Quality
Time Frame: At baseline and at the end of the intervention period (week 17)
Instrumented motion analysis will be conducted through the usage of inertial sensors to assess changes from baseline in spatiotemporal and kinematics parameters during walking, turning and stepping tasks
At baseline and at the end of the intervention period (week 17)
Balance
Time Frame: At baseline and at the end of the intervention period (week 17)
The Mini-BESTest: Balance Evaluation Systems Test will be used to measure changes from baseline in balance (score range: 0-28, higher scores mean a better outcome)
At baseline and at the end of the intervention period (week 17)
Endurance
Time Frame: At baseline and at the end of the intervention period (week 17)
The 2-minute Step Test will be used to assess changes from baseline in aerobic capacity
At baseline and at the end of the intervention period (week 17)
Lower limb strength and power
Time Frame: At baseline and at the end of the intervention period (week 17)
The 30s Sit to Stand will be used to assess changes from baseline in lower limb strength and power
At baseline and at the end of the intervention period (week 17)
Hand grip strength
Time Frame: At baseline and at the end of the intervention period (week 17)
The Hand Grip strength Test will be used to assess changes from baseline in hand grip strength
At baseline and at the end of the intervention period (week 17)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: At baseline and at the end of the intervention period (week 17)
The WHOQOL-BREF will be used to assess changes from baseline in quality of life (score range: 4-20 for each domain, higher scores mean a better outcome)
At baseline and at the end of the intervention period (week 17)
Depression symptoms
Time Frame: At baseline and at the end of the intervention period (week 17)
The Geriatric Depression Scale will be used to assess changes from baseline in depressive symptoms (score range: 0-15, higher scores mean a worse outcome)
At baseline and at the end of the intervention period (week 17)
Anxiety symptoms
Time Frame: At baseline and at the end of the intervention period (week 17)
The State-Trait Anxiety Inventory will be used to assess changes in anxiety symptoms from baseline (score range: 0-20, higher scores mean a worse outcome)
At baseline and at the end of the intervention period (week 17)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

February 25, 2026

First Submitted That Met QC Criteria

March 19, 2026

First Posted (Actual)

March 27, 2026

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 19, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Subscribe